Stem Cell Therapy
別名: stem cell treatment, regenerative cell therapy, 줄기세포 치료
Stem cell therapy is a medical treatment that uses stem cells or their derivatives to repair, replace or regenerate damaged tissue, cells or organs.
Is stem cell therapy FDA approved?
Only for a few specific uses. The FDA says its approved stem cell products are cord blood-derived blood-forming cell products for disorders of the blood-forming system. Its approved-products register also lists Ryoncil, a mesenchymal stromal cell therapy approved in December 2024 for steroid-refractory acute GVHD in children, and Omisirge. The FDA warns that most other stem cell, cord blood, Wharton's jelly and exosome products marketed to consumers are not approved.
主要な事実
| 項目 | 値 | 出典 |
|---|---|---|
| Entity type | Medical treatment | 確認中 |
| Most established use | Hematopoietic stem cell transplantation for blood and immune disorders | [1]governmentStem Cell BasicsNational Institutes of Health (NIH) |
| Regulator (United States) | U.S. Food and Drug Administration (FDA) | [2]governmentFDA Warns About Stem Cell TherapiesU.S. Food and Drug Administration |
| Regulator (South Korea) | Ministry of Food and Drug Safety (MFDS) | [3]governmentMinistry of Food and Drug Safety — English siteMFDS, Republic of Korea |
| Typical cost range (Korea) | [PRICE RANGE — pending verified source] | 確認中 |
概要
Stem cell therapy covers a range of treatments that introduce stem cells or stem-cell-derived products into a patient. The most established use is hematopoietic stem cell transplantation for blood disorders. Many other uses marketed to consumers remain investigational, and regulators such as the U.S. FDA have warned about unapproved products. Patients should confirm regulatory approval status, clinical trial registration and the treating institution's credentials.
参考文献
独立出典比率 100% (3/3)- レベル A · governmentStem Cell Basics — National Institutes of Health (NIH) · 閲覧日 2026年9月15日 · 根拠ページ
- レベル A · governmentFDA Warns About Stem Cell Therapies — U.S. Food and Drug Administration · 閲覧日 2026年9月15日 · 根拠ページ
- レベル A · governmentMinistry of Food and Drug Safety — English site — MFDS, Republic of Korea · 閲覧日 2026年9月22日 · 根拠ページ